These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction. Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791 [TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of ACE inhibitors: insights from animal models. Drexler H Int J Clin Pract Suppl; 1999 Apr; 100():3-5. PubMed ID: 10658289 [No Abstract] [Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors and myocardial infarction: a class effect? Krantz MJ; Estacio RO; Mehler PS Am J Cardiol; 2005 Apr; 95(7):924. PubMed ID: 15781039 [No Abstract] [Full Text] [Related]
10. [Beneficial effects of Hartil on cardiovascular remodeling process in elderly and old patients with isolated systolic arterial hypertension]. Kiphshidze N; Zubiashvili T; Chagunava K Georgian Med News; 2008 Jan; (154):7-13. PubMed ID: 18323584 [TBL] [Abstract][Full Text] [Related]
11. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Wald DS; Law M; Morris JK; Bestwick JP; Wald NJ Am J Med; 2009 Mar; 122(3):290-300. PubMed ID: 19272490 [TBL] [Abstract][Full Text] [Related]
12. Risk factor-induced cardiovascular remodeling and the effects of angiotensin-converting enzyme inhibitors. Galderisi M; de Divitiis O J Cardiovasc Pharmacol; 2008 Jun; 51(6):523-31. PubMed ID: 18520954 [TBL] [Abstract][Full Text] [Related]
13. More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension. Kjeldsen SE; Hedner T; Narkiewicz K; Oparil S Blood Press; 2008; 17(3):132-3. PubMed ID: 18665471 [No Abstract] [Full Text] [Related]
14. [Clinical uses and evaluation of angiotensin converting enzyme inhibitor]. Chen HZ Zhonghua Yi Xue Za Zhi; 1995 Feb; 75(2):67-8. PubMed ID: 7767768 [No Abstract] [Full Text] [Related]
15. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure. Björck S; Aurell M J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067 [TBL] [Abstract][Full Text] [Related]
16. Effects of antihypertensive drug treatment on the risk of dementia and cognitive impairment. Poon IO Pharmacotherapy; 2008 Mar; 28(3):366-75. PubMed ID: 18294116 [TBL] [Abstract][Full Text] [Related]
17. Zenon's paradox or how much to lower blood pressure for optimal renoprotection. Wolf G Nephrol Dial Transplant; 2005 Nov; 20(11):2304-7. PubMed ID: 16030041 [No Abstract] [Full Text] [Related]
18. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis. Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534 [TBL] [Abstract][Full Text] [Related]
19. Management of hypertension in patients with cardiac disease: use of renin-angiotensin blocking agents. Prisant LM Am J Med; 2008 Aug; 121(8 Suppl):S8-15. PubMed ID: 18638617 [TBL] [Abstract][Full Text] [Related]
20. A new prognostic factor for myocardial infarction recovery. Yamamoto K Hypertens Res; 2008 Jul; 31(7):1269-70. PubMed ID: 18957792 [No Abstract] [Full Text] [Related] [Next] [New Search]